Trial Profile
An observational study to investigate the incidence of influenza, downstream complications of influenza and hospitalizations, in elderly subjects vaccinated with GSK Biologicals' influenza vaccine (Fluarix) administered intramuscularly.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 17 Sep 2007 Status changed from in progress to completed.
- 25 Oct 2006 New trial record.